Micrus Slashes Outlook
Shares of Micrus Endovascular Corp. (MEND) plummeted $6.20 to close at $17.37 after the drug company slashed its revenue outlook due to regulatory delays in Asia.
posted by FC Market News at 9:26 AM
Tuesday, September 18, 2007
Previous Posts
- Enterra Suspends Monthly Distribution
- Newell Lifts Guidance
- Central Garden Withdraws Outlook
- Brocade Upgraded
- iRobot Loses Contract
- Idearc Buys InfoSpace's Online Directory Business
- Cardinal Health Trims Outlook
- First Acceptance Swings To Loss
- ImClone Downgraded
- American Express Downgraded
0 Comments:
Post a Comment
<< Home